BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 10613099)

  • 1. [Endothelial function in coronary atherosclerosis and heart failure--the role of nitric oxide in regulation of vasomotor tone].
    Andreassen AK; Kirkebøen KA
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4066-9. PubMed ID: 10613099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial function and dysfunction in heart failure.
    Ferrari R; Bachetti T; Agnoletti L; Comini L; Curello S
    Eur Heart J; 1998 Jul; 19 Suppl G():G41-7. PubMed ID: 9717055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction in chronic heart failure. Experimental and clinical studies.
    Drexler H; Hayoz D; Münzel T; Just H; Zelis R; Brunner HR
    Arzneimittelforschung; 1994 Mar; 44(3A):455-8. PubMed ID: 8185723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences].
    Patti G; Melfi R; Di Sciascio G
    Recenti Prog Med; 2005 Oct; 96(10):499-507. PubMed ID: 16491775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endothelial regulation of coronary circulation: current status].
    Schächinger V; Zeiher AM
    Z Kardiol; 1996; 85 Suppl 6():263-7. PubMed ID: 9064975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelium dysfunction in the coronary circulation.
    Lüscher TF; Noll G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S16-26. PubMed ID: 7700060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial control of vascular tone in chronic heart failure.
    Kiowski W; Sütsch G; Schalcher C; Brunner HP; Oechslin E
    J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S67-73. PubMed ID: 9883751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endothelial dysfunction in cardial failure: potential mechanisms].
    Varin R; Mulder P; Richard V; Thuillez C
    Arch Mal Coeur Vaiss; 1997 Nov; 90 Spec No 6():29-34. PubMed ID: 9515111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure.
    Tousoulis D; Charakida M; Stefanadis C
    Int J Cardiol; 2005 Apr; 100(3):347-53. PubMed ID: 15837076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure.
    Hornig B; Arakawa N; Drexler H
    Eur Heart J; 1998 Jul; 19 Suppl G():G48-53. PubMed ID: 9717056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of type 5 phosphodiesterase inhibition in the treatment of congestive heart failure.
    Katz SD
    Congest Heart Fail; 2003; 9(1):9-15. PubMed ID: 12556672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelium-derived relaxing factor in human coronary artery.
    Bossaller C; Fleck E
    Z Kardiol; 1989; 78 Suppl 6():59-63. PubMed ID: 2694666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive changes of the vascular system in heart failure. Potential role of impaired endothelial vasomotor function.
    Pohl U
    Herz; 1993 Dec; 18 Suppl 1():395-9. PubMed ID: 7907307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive evaluation of endothelial function.
    Bae JH
    J Cardiol; 2001; 37 Suppl 1():89-92. PubMed ID: 11433834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of nitric oxide in heart failure].
    Le Corvoisier P; Lopes ME; Su J; Hittinger L
    J Soc Biol; 2000; 194(3-4):143-9. PubMed ID: 11324316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atherosclerosis and endothelium-derived relaxing factor].
    Bossaller C; Fleck E
    Med Klin (Munich); 1990 Feb; 85 Suppl 1():13-8. PubMed ID: 2185402
    [No Abstract]   [Full Text] [Related]  

  • 18. Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects.
    Heitzer T; Rudolph V; Schwedhelm E; Karstens M; Sydow K; Ortak M; Tschentscher P; Meinertz T; Böger R; Baldus S
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1648-52. PubMed ID: 16675725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise training and vascular cell phenotype in a swine model of familial hypercholesterolaemia: conduit arteries and veins.
    Simmons GH; Padilla J; Jenkins NT; Laughlin MH
    Exp Physiol; 2014 Feb; 99(2):454-65. PubMed ID: 24213857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium and the regulation of vascular tone with emphasis on the role of nitric oxide. Physiology, pathophysiology and clinical implications.
    Rongen GA; Smits P; Thien T
    Neth J Med; 1994 Jan; 44(1):26-35. PubMed ID: 8202203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.